Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H22O5 |
| Molecular Weight | 354.3964 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(CC=C(C)C)C(OC)=C2C=C(OC2=C1)C3=C(O)C=C(O)C=C3
InChI
InChIKey=DKVBYQAVNNRVNN-UHFFFAOYSA-N
InChI=1S/C21H22O5/c1-12(2)5-7-15-18(24-3)11-20-16(21(15)25-4)10-19(26-20)14-8-6-13(22)9-17(14)23/h5-6,8-11,22-23H,7H2,1-4H3
| Molecular Formula | C21H22O5 |
| Molecular Weight | 354.3964 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL613740 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26841168 |
|||
Target ID: CHEMBL357 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24686577 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:55:23 GMT 2025
by
admin
on
Mon Mar 31 22:55:23 GMT 2025
|
| Record UNII |
6XTP69UV3S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
480777
Created by
admin on Mon Mar 31 22:55:23 GMT 2025 , Edited by admin on Mon Mar 31 22:55:23 GMT 2025
|
PRIMARY | |||
|
6XTP69UV3S
Created by
admin on Mon Mar 31 22:55:23 GMT 2025 , Edited by admin on Mon Mar 31 22:55:23 GMT 2025
|
PRIMARY | |||
|
126716-36-7
Created by
admin on Mon Mar 31 22:55:23 GMT 2025 , Edited by admin on Mon Mar 31 22:55:23 GMT 2025
|
PRIMARY | |||
|
DTXSID90155275
Created by
admin on Mon Mar 31 22:55:23 GMT 2025 , Edited by admin on Mon Mar 31 22:55:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
GANCAONIN I showed antibacterial activity against MSSAs (strains FDA 209P and Smith) and MRSAs(strains K3 and ST 28) (MICs1.56?25 ug/ml). This compound exhibited antimicrobial activity against Micrococcus luteus ATCC 9341 and Bacillus subtilis PCI 219 (MICs3.13?25 ug/ml) but not against Klebsiella pneumoniae PCI 602 and Pseudomonas aeruginosa IFO 3445.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|